Injectable BPC-157 is administered subcutaneously or intramuscularly, completely bypassing the digestive system
This suggests the health of the pancreas prior to drug initiation may be an important determinant of the rate of proliferation with GLP-1RA treatment
However, the mechanisms in humans are still being studied, and larger randomized trials are needed to figure out how generalizable these effects are
Talk about your goals, your fears, what keeps you up at night worrying about money, all of it
Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, et al
If you're considering GLP-1 treatment and have RA, it's essential to continue your RA medications, adopt healthy lifestyle habits, and work closely with your healthcare provider to ensure safe, effective use